| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1423-0410.1994.TB00270.X |
| P698 | PubMed publication ID | 8146977 |
| P2093 | author name string | L Muylle | |
| M E Peetermans | |||
| P433 | issue | 1 | |
| P304 | page(s) | 14-17 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Vox Sanguinis | Q15708866 |
| P1476 | title | Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates | |
| P478 | volume | 66 |
| Q40640145 | Analysis of transfusion incident reports filed at 15 blood transfusion centers and health facilities during 17 months. Groupe Receveurs de laSFTS |
| Q33579626 | Are cytokines in platelet concentrates responsible for febrile transfusion reactions? |
| Q37429101 | CD40 ligand (CD154) involvement in platelet transfusion reactions |
| Q30470253 | Comparison of platelet loss during leukocyte reduction at 4, 24, and 48 hours postcollection using a Closed System Apheresis Kit with Integral filter |
| Q38206749 | Considerations for the use of platelet-rich plasma in orthopedics |
| Q74107507 | Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction |
| Q37867951 | Effects of storage of red cells |
| Q43629600 | Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. |
| Q40628811 | Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations |
| Q43086824 | Impacts of leukocyte filtration and irradiation on coagulation factors in fresh frozen plasma |
| Q35412740 | Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage. |
| Q33835138 | Leukocyte reduction of blood components: public policy and new technology |
| Q33760699 | Leukoreduced blood components: Advantages and strategies for its implementation in developing countries |
| Q33361167 | Optimizing platelet transfusion therapy |
| Q43567166 | Pooled platelet concentrates: an alternative to single donor apheresis platelets? |
| Q73821776 | Prevention of monocyte adhesion and inflammatory cytokine production during blood platelet storage: an in vitro model with implications for transfusion practice |
| Q40607411 | Quality of platelet components: the role of suspension medium and leukocyte depletion |
| Q72607352 | Quality of pooled platelet concentrates prepared from buffy coats and stored in an additive solution after filtration |
| Q36292232 | Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. |
| Q36405146 | Simple tube centrifugation for processing platelet-rich plasma in the horse |
| Q79095562 | Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, β‐thromboglobulin, platelet factor 4 and interleukin‐7, during storage |
| Q41480031 | The inflammatory response and extracorporeal circulation |
| Q33579652 | The red cell storage lesion and its implication for transfusion |
| Q40426156 | The role of cytokines in blood transfusion reactions |
| Q30464942 | The use of leukocyte-reduced blood components. |
| Q72279715 | [Preparation of platelet concentrates from donated total blood] |
Search more.